Kimball Electronics, Inc. · NASDAQ:KE

Kimball Electronics — Q3 2026 Earnings Presentation

33 slides from Kimball Electronics's earnings presentation, May 6, 2026

  1. Slide 1: Third Quarter Fiscal 2026 Results

    Third Quarter Fiscal 2026 Results Quarter Ended March 31, 2026 Supplementary Information to the May 6, 2026, Earnings Conference Call & Webcast Lasting relationships. Global success. Kimball Electronics Confidential

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Certain statements contained within this supplementary information, including our fiscal year 2026 guidance, and any statements made during our earnings conference call today may be considered forward-looking under the Private Securities Litigation Reform Act of 1995. The state

  3. Slide 3: Today's Speakers and Agenda

    Today’s Speakers Agenda • Opening comments • Financial results for the quarter • Guidance for fiscal 2026 • Closing comments Ric Phillips Jana Croom • Q&A CEO CFO Lasting relationships. Global success. Kimball Electronics | 3

  4. Slide 4: Results For The Third Quarter Were In-line With Expectations

    Results For The Third Quarter Were In-line With Expectations • Sales increased sequentially when compared with Q2 • Driven by strong growth in our medical market • Margins remain solid • Cash from operations was positive for the ninth consecutive quarter • Expecting Q4 to be a good finish to the yea

  5. Slide 5: Medical CMO Continues to be Key Part of Our Strategy

    Medical CMO Continues to be Key Part of Our Strategy • Deliberate investments in our capabilities, operating capacity and commercial focus • When volumes ramp, we expect it to become a meaningful driver to both top line growth and margin expansion • Focus on inorganic growth as a possible complement

  6. Slide 6: $353M Net Sales

    Industrial 24% Medical 30% $353M Net Sales Automotive 46% • Increase of +3.4% compared to the prior quarter • Medical vertical up +10% • 6% decline compared to Q3 last year • All three market verticals were down • Q3 FY25 included $24M of non-recurring inventory sale in the medical market • Normaliz

  7. Slide 7: $106M Medical Net Sales

    Medical $106M Net Sales • 30% of our company, reaching nearly one third of our total portfolio • An important Milestone in our strategic objective to balance the verticals with a higher concentration of medical business • North America represented just under half of sales, with Asia and Europe split

  8. Slide 8: Medical Remains a Compelling Opportunity to Diversify Our Top Line

    Medical Remains a Compelling Opportunity to Diversify Our Top Line and Leverage Our Core Strengths • Strategic focus on supporting new and existing blue-chip customers in need of manufacturing capacity, keeping pace with the overall market growth with our state-of- the-art manufacturing facility in

  9. Slide 9: $161M Automotive Net Sales

    Automotive $161M Net Sales • Decline primarily in Asia and North America, partially offset by growth in Europe • Ramping new programs in steering and braking systems in Europe, up +20% in this quarter; we expect this strength to continue ** for the balance of ‘26 • Carefully monitoring electronic st

  10. Slide 10: Industrial Net Sales $86M

    Industrial Net Sales $86M • Lower demand for HVAC systems, mainly in North America • Decline in off highway equipment and green energy • Partially offset by higher sales in: • Public safety • Rebound of the smart metering business in ** Europe • May be impacted near-term by a protracted war in the M

  11. Slide 11: Net Sales in the Third Quarter were $352.9 million

    Net Sales in the Third Quarter were $352.9 million • (6%) decrease year-over-year • Foreign exchange +3% favorable impact • On a sequential basis, sales increased +3.4% • Driven by growth in the Medical vertical Lasting relationships. Global success. Kimball Electronics | 11

  12. Slide 12: Gross Margin in the Third Quarter was 7.9%

    Gross Margin in the Third Quarter was 7.9% • +70 bps improvement compared to 7.2% in Q3 fiscal year 2025 • Increase resulting from favorable mix • Offset by: • The ramp up of the medical CMO • A somewhat easier comparison as the inventory sales we experienced in Q3 of FY25 had very little margin • W

  13. Slide 13: Adjusted Selling & Administrative Expense

    Adjusted Selling & Administrative Expense(1) • Second quarter $13 million • +$1.8 million increase year-over-year • When measured as percent of sales the rate was 3.7% this year compared to 3.0% last year • Higher FY26 expense as we make strategic investments for the future • Business transformation

  14. Slide 14: Adjusted Operating Income in the Third Quarter of 4.2%

    Adjusted Operating Income in the Third Quarter of 4.2%(1) • $14.8 million, or 4.2% of net sales • Compares to last year’s adjusted result of $15.7 million, or 4.2% of net sales (1) Adjusted Operating Income is a Non-GAAP measure – refer to Reconciliation of Non-GAAP Results in the supplementary info

  15. Slide 15: Other Income / Expense

    Other Income / Expense • Expense of $3.0 million, compared to $4.6M of expense last year • Interest expense drove the decrease, down nearly 30% year-over-year Lasting relationships. Global success. Kimball Electronics | 15

  16. Slide 16: Effective Tax Rate

    Effective Tax Rate • 34.9%, compared to 46.6% last year • Q3 of last year was driven by the limitation of the tax deductibility of our interest expense • Cannot exceed a certain percentage of domestic EBIT • For the full year of fiscal 2026, we continue to expect an effective tax rate of approx. 30%

  17. Slide 17: Adjusted Net Income and Adjusted Diluted EPS

    Adjusted Net Income and Adjusted Diluted EPS (1) (1) Adjusted Net Income and Adjusted Diluted EPS are Non-GAAP measures – refer to Reconciliation of Non-GAAP Results in the supplementary information. Lasting relationships. Global success. v Kimball Electronics | 17

  18. Slide 18: Our Balance Sheet Remains Strong

    Our Balance Sheet Remains Strong • Cash and cash equivalents at March 31, 2026, were $82.5 million • Cash generated by operating activities in the quarter was $14.9 million, our ninth consecutive quarter of positive cash flow • Cash conversion days were 90, 1-day improvement compared to last quarter

  19. Slide 19: Inventory Ended the Quarter at $273.3 million

    Inventory Ended the Quarter at $273.3 million • Reduction of $8.4M compared to Q2, and down $23.3 million - or 8% - from a year ago Lasting relationships. Global success. Kimball Electronics | 19

  20. Slide 20: Capital Expenditures for the Quarter $14.4 million

    Capital Expenditures for the Quarter $14.4 million (1) • Spend on leasehold improvements in the new facility in Indianapolis • Balanced by spend to support new programs in Europe • Expecting capex for fiscal year 2026 to be in the guidance range of $50-$60M (1) Capital Expenditures include purchases

  21. Slide 21: Borrowings at March 31, 2026, were $163 million

    Borrowings at March 31, 2026, were $163 million • Up $8.8 million from the second quarter • Down $15.8 million, or ~9%, from a year ago • Short-term liquidity totaled $358.5 million at the end of the third quarter • In April, we renewed our $300M revolver • Maintaining strong balance sheet to suppor

  22. Slide 22: Share Repurchases

    Share Repurchases • Invested $4.0 million to repurchase 165,000 shares • Since October 2015, under our Board authorized share repurchase program: • A total of $113.5 million returned to Share Owners by repurchasing 7 million shares of common stock • $6.5 million remaining on the repurchase program L

  23. Slide 23: Affirming FY26 Guidance, Expect Adjusted OI Margin at High End

    Affirming FY26 Guidance, Expect Adjusted OI Margin Range at the High End of the Range • Expecting a good finish to Q4: FY26 Guidance • Sales $370-$380M Sales $1.40-$1.46B • Adj OI margin 4.4%-4.6% Adj OI Margin 4.2%-4.5% Capital Investments $50-$60M Lasting relationships. Global success. Kimball Ele

  24. Slide 24: Expecting a Good Finish to the Fiscal Year

    Expecting a Good Finish to the Fiscal Year • Expecting another sequential increase in sales in Q4 • Medical Vertical continues to outpace the other two verticals • Monitoring impacts of the war in Iran • Higher freight and raw materials costs • Higher energy prices • Consumer sentiment Lasting relat

  25. Slide 25: Looking Ahead

    Looking Ahead • Evaluate strategic opportunities, that could accelerate the expansion of our medical CMO business • Strong inorganic growth potential • Established medical manufacturers – outside the US – seeking domestic market entry and scaled US production • Adding complementary capabilities such

  26. Slide 26: Questions

    Questions Lasting relationships. Global success. Kimball Electronics | 26

  27. Slide 27: For more information, please contact:

    For more information, please contact: Andy Regrut Vice President, Investor Relations, Strategic Development, and Treasurer 812–827–4151 andy.regrut@kimballelectronics.com Lasting relationships. Global success. Kimball Electronics | 27

  28. Slide 28: Appendix

    Appendix Lasting relationships. Global success. Kimball Electronics | 28

  29. Slide 29: Reconciliation of non-GAAP results

    Reconciliation of non-GAAP results (Unaudited, Amounts in Thousands, Except Per Share Data) Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Net Sales Growth (vs. same quarter in prior year) (12) % (12) % (2) % (5) % (6) % Foreign Currency Exchange Impact (1) % 1 % 1 % 2 % 3 % Constant Currency Growth (11) % (13) % (3

  30. Slide 30: Reconciliation of non-GAAP results continued

    Reconciliation of non-GAAP results continued…. (Unaudited, Amounts in Thousands, Except Per Share Data) Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Operating Income (GAAP) (TTM) $ 48,669 $ 45,535 $ 50,874 $ 53,411 $ 53,450 Add: Asset Impairment (Gain on Disposal) (TTM) (788) (2,391) (1,251) (829) (833) Add: Restr

  31. Slide 31: Net Sales in Automotive

    Net Sales in Automotive (1) (1) Beginning in the first quarter of fiscal year 2026, sales to customers related to commercial transportation, previously included in the automotive vertical, are now reflected in the industrial vertical. Prior periods have been recast to conform to current period prese

  32. Slide 32: Net Sales in Medical

    Net Sales in Medical (1) (1) Q3’25 includes $24 million of non-recurring consignment inventory sales. Lasting relationships. Global success. Kimball Electronics | 32

  33. Slide 33: Net Sales in Industrial

    Net Sales in Industrial (1) (1) Beginning in the first quarter of fiscal year 2026, sales to customers related to commercial transportation, previously included in the automotive vertical, are now reflected in the industrial vertical. Prior periods have been recast to conform to current period prese

Kimball Electronics — Q3 2026 Earnings Presentation on 6ix